Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | CASP1 | P29466 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.43 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.43 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.43 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | GGT1 | P19440 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5030952 | 0.87 | NPC1 (0.58) | NPSR1L3MBTL1HTTSMN1; SMN2CTNNB1 | |
| SCHEMBL9769889 | 0.86 | NPSR1 (0.58) | NPSR1L3MBTL1SMN1; SMN2CYP3A4CTNNB1 | |
| SCHEMBL689888 | 0.85 | POLB (0.43) | NPSR1L3MBTL1SMN1; SMN2CYP3A4NPC1 | |
| SCHEMBL29539667 | 0.84 | NPSR1 (0.56) | NPSR1L3MBTL1HTTSMN1; SMN2CTNNB1 | |
| SCHEMBL294263 | 0.84 | NPSR1 (0.56) | NPSR1L3MBTL1HTTSMN1; SMN2CTNNB1 | |
| SCHEMBL699305 | 0.83 | PSEN1 (0.49) | NPSR1L3MBTL1HTTCTNNB1NPC1 | |
| SCHEMBL10686662 | 0.82 | NPSR1 (0.55) | NPSR1L3MBTL1HTTSMN1; SMN2CTNNB1 | |
| SCHEMBL8672557 | 0.80 | HTT (0.54) | NPSR1L3MBTL1HTTCYP2C9ALDH1A1 | |
| SCHEMBL28411450 | 0.80 | CTNNB1 (0.66) | L3MBTL1HTTSMN1; SMN2CTNNB1POLB | |
| SCHEMBL10435899 | 0.78 | CYP3A4 (0.54) | HTTSMN1; SMN2CYP3A4NPC1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260117044-A1 | PHENOLIC COMPOUND, ORGANIC MATERIAL STABILIZER, RESIN COMPOSITION, AND METHOD FOR STABILIZING ORGANIC MATERIAL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2026-04-30 | — | — | US | disclosed |
| EP-4180482-B1 | MOISTURE-CURABLE COMPOSITION | NITTO KASEI CO LTD (JP) | 2025-12-03 | — | — | EP | disclosed |
| EP-4650401-A1 | PROCESSING STABILIZER, RESIN COMPOSITION, AND ORGANIC MATERIAL STABILIZING METHOD | Sumitomo Chemical Company, Limited (JP) | 2025-11-19 | — | — | EP | disclosed |
| US-20250171476-A1 | PROCESS STABILIZER, ORGANIC MATERIAL COMPOSITION, AND METHOD FOR STABILIZING ORGANIC MATERIAL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-05-29 | — | — | US | disclosed |
| EP-4488337-A1 | PROCESS STABILIZER, ORGANIC MATERIAL COMPOSITION, AND METHOD FOR STABILIZING ORGANIC MATERIAL | Sumitomo Chemical Company, Limited (JP) | 2025-01-08 | — | — | EP | disclosed |
| US-20240166672-A1 | PHOSPHOROUS ESTER COMPOUND, METHOD FOR PRODUCING SAME AND USE APPLICATION FOR SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-05-23 | — | — | US | disclosed |
| EP-4371988-A1 | PHENOLIC COMPOUND, ORGANIC MATERIAL STABILIZER, RESIN COMPOSITION, AND METHOD FOR STABILIZING ORGANIC MATERIAL | Sumitomo Chemical Company, Limited (JP) | 2024-05-22 | — | — | EP | disclosed |
| EP-4317166-A1 | PHOSPHOROUS ESTER COMPOUND, METHOD FOR PRODUCING SAME, AND USE APPLICATION FOR SAME | Sumitomo Chemical Company Limited (JP) | 2024-02-07 | — | — | EP | disclosed |
| EP-4180482-A1 | MOISTURE-CURABLE COMPOSITION | Nitto Kasei Co., Ltd. (JP) | 2023-05-17 | — | — | EP | disclosed |
| EP-3880441-A1 | METHOD FOR PRODUCING AN ADDITIVELY MANUFACTURED AND TREATED OBJECT | Covestro Intellectual Property GmbH & Co. KG (DE) | 2021-09-22 | — | — | EP | disclosed |
| EP-2565238-A1 | METALLIC-PIGMENT COMPOSITION | Asahi Kasei Chemicals Corporation (JP) | 2013-03-06 | — | — | EP | disclosed |
| EP-2554608-A1 | METALLIC PIGMENT COMPOSITION | Asahi Kasei Chemicals Corporation (JP) | 2013-02-06 | — | — | EP | disclosed |
| US-20130011639-A1 | METALLIC PIGMENT COMPOSITION | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2013-01-10 | — | — | US | disclosed |
| US-8252273-B2 | Ultraviolet absorber | LEAD CHEMICAL CO., LTD. (JP) | 2012-08-28 | — | — | US | disclosed |
| US-20120088875-A1 | STABILIZER COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-04-12 | — | — | US | disclosed |
| EP-2423251-A1 | STABILIZER COMPOSITION | Sumitomo Chemical Company, Limited (JP) | 2012-02-29 | — | — | EP | disclosed |
| US-20100239508-A1 | ULTRAVIOLET ABSORBER | LEAD CHEMICAL CO., LTD. (JP) | 2010-09-23 | — | — | US | disclosed |
| US-20080152927-A1 | Coating composition applicable to nonpolar resin substrate, multilayer coat forming method using the same, and coated resin product | TOYODA GOSEI CO., LTD. (JP) | 2008-06-26 | — | — | US | disclosed |
| US-6306502-B1 | COMPOSITION COMPRISING ULTRAVIOLET-CURABLE SILICONE, MONOMER MIXTURE COMPRISING TRIS((METH)ACRYLOYLOXYALKYL)ISOCYANURATE AND URETHANE POLY(METH)ACRYLATE HAVING ALICYCLIC SKELETON, PHOTOPOLYMERIZATION INITIATOR | MITSUBISHI RAYON CO., LTD. (JP) | 2001-10-23 | — | — | US | disclosed |
| EP-0869154-A1 | COATING COMPOSITION FORMING WEAR-RESISTANT COAT AND ARTICLE COVERED WITH THE COAT | MITSUBISHI RAYON CO., LTD. (JP) | 1998-10-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260117044-A1 | PHENOLIC COMPOUND, ORGANIC MATERIAL STABILIZER, RESIN COMPOSITION, AND METHOD FOR STABILIZING ORGANIC MATERIAL | PIEZO1, TERB1, RPA1 | NPSR1 4005/4885L3MBTL1 448/4885HTT 3333/4885 |
| US-20240166672-A1 | PHOSPHOROUS ESTER COMPOUND, METHOD FOR PRODUCING SAME AND USE APPLICATION FOR SAME | EBPL, ACSL6, ACSL3 | NPSR1 3885/4885L3MBTL1 4081/4885HTT 4263/4885 |
| US-20100239508-A1 | ULTRAVIOLET ABSORBER | UNG, UACA, ABCG2 | NPSR1 2777/4885L3MBTL1 4628/4885HTT 1302/4885 |
| US-20250171476-A1 | PROCESS STABILIZER, ORGANIC MATERIAL COMPOSITION, AND METHOD FOR STABILIZING ORGANIC MATERIAL | APOL1, ATXN2L, CCNL2 | NPSR1 2617/4885L3MBTL1 1427/4885HTT 630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.